• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化物酶体增殖物激活受体(PPAR)γ:在脂肪组织中占主导性表达且在脂肪细胞分化早期被诱导。

Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation.

作者信息

Chawla A, Schwarz E J, Dimaculangan D D, Lazar M A

机构信息

Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104.

出版信息

Endocrinology. 1994 Aug;135(2):798-800. doi: 10.1210/endo.135.2.8033830.

DOI:10.1210/endo.135.2.8033830
PMID:8033830
Abstract

Activators of peroxisome proliferator activated receptor (PPAR) regulate fatty acid metabolism and can induce adipocyte differentiation. We show here that the gamma subtype of PPAR is expressed at high levels in adipose tissue in contrast to a variety of other tissues, where little gene expression was noted. In addition, PPAR gamma is present at low levels in 3T3-L1 preadipocytes and is induced dramatically during adipocyte conversion using either normal differentiating conditions (fetal calf serum, dexamethasone, isobutyl-methylxanthine, and insulin) or the PPAR activator, WY-14,643. Thus PPAR gamma may be important for adipose cell development and function.

摘要

过氧化物酶体增殖物激活受体(PPAR)的激活剂可调节脂肪酸代谢,并能诱导脂肪细胞分化。我们在此表明,与多种其他组织相比,PPAR的γ亚型在脂肪组织中高水平表达,而在这些其他组织中几乎没有基因表达。此外,PPARγ在3T3-L1前脂肪细胞中低水平存在,并且在使用正常分化条件(胎牛血清、地塞米松、异丁基甲基黄嘌呤和胰岛素)或PPAR激活剂WY-14,643进行脂肪细胞转化过程中会显著诱导表达。因此,PPARγ可能对脂肪细胞的发育和功能很重要。

相似文献

1
Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation.过氧化物酶体增殖物激活受体(PPAR)γ:在脂肪组织中占主导性表达且在脂肪细胞分化早期被诱导。
Endocrinology. 1994 Aug;135(2):798-800. doi: 10.1210/endo.135.2.8033830.
2
Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.小鼠肥胖时肝脏中过氧化物酶体增殖物激活受体(PPAR-α)和PPAR-γ信使核糖核酸表达上调:曲格列酮诱导肥胖糖尿病小鼠肝脏中PPAR-γ反应性脂肪组织特异性基因的表达。
Endocrinology. 2000 Nov;141(11):4021-31. doi: 10.1210/endo.141.11.7771.
3
Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.过氧化物酶体增殖物激活受体基因在人体组织中的表达。肥胖、体重减轻以及胰岛素和糖皮质激素的调节作用。
J Clin Invest. 1997 May 15;99(10):2416-22. doi: 10.1172/JCI119424.
4
Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.恶性乳腺上皮细胞分泌的肿瘤坏死因子α和白细胞介素11通过选择性下调CCAAT/增强子结合蛋白α和过氧化物酶体增殖物激活受体γ来抑制脂肪细胞分化:促结缔组织增生反应的机制
Cancer Res. 2001 Mar 1;61(5):2250-5.
5
Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver.大鼠肝脏中过氧化物酶体增殖物激活受体-α mRNA的调控
Arch Biochem Biophys. 1996 Feb 15;326(2):281-9. doi: 10.1006/abbi.1996.0077.
6
Prolactin enhances CCAAT enhancer-binding protein-beta (C/EBP beta) and peroxisome proliferator-activated receptor gamma (PPAR gamma) messenger RNA expression and stimulates adipogenic conversion of NIH-3T3 cells.催乳素可增强CCAAT增强子结合蛋白β(C/EBPβ)和过氧化物酶体增殖物激活受体γ(PPARγ)信使核糖核酸的表达,并刺激NIH-3T3细胞的成脂转化。
Mol Endocrinol. 2000 Feb;14(2):307-16. doi: 10.1210/mend.14.2.0420.
7
Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients.过氧化物酶体增殖物激活受体和肝脏X受体-α的mRNA在人体中的组织分布及表达定量:肥胖和非胰岛素依赖型糖尿病患者脂肪组织无改变
Diabetes. 1997 Aug;46(8):1319-27. doi: 10.2337/diab.46.8.1319.
8
Transcription suppression of peroxisome proliferator-activated receptor gamma2 gene expression by tumor necrosis factor alpha via an inhibition of CCAAT/ enhancer-binding protein delta during the early stage of adipocyte differentiation.在脂肪细胞分化早期,肿瘤坏死因子α通过抑制CCAAT/增强子结合蛋白δ来抑制过氧化物酶体增殖物激活受体γ2基因表达的转录。
Endocrinology. 2004 Nov;145(11):4948-56. doi: 10.1210/en.2004-0180. Epub 2004 Jul 29.
9
Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR gamma hypomorphic mice.肌肉的代偿作用限制了PPARγ低表达小鼠脂肪营养不良的代谢后果。
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14457-62. doi: 10.1073/pnas.2336090100. Epub 2003 Nov 5.
10
Induction of the nuclear orphan receptor RORgamma during adipocyte differentiation of D1 and 3T3-L1 cells.在D1和3T3-L1细胞的脂肪细胞分化过程中核孤儿受体RORγ的诱导。
Cell Growth Differ. 1998 Mar;9(3):267-76.

引用本文的文献

1
Selective PPARα Modulator (SPPARMα) in the Era of the MASLD Pandemic: Current Insights and Future Prospects.非酒精性脂肪性肝病大流行时代的选择性过氧化物酶体增殖物激活受体α调节剂(SPPARMα):当前见解与未来展望
Yonago Acta Med. 2025 Apr 24;68(2):91-105. doi: 10.33160/yam.2025.05.002. eCollection 2025 May.
2
Endocrine-disrupting chemicals as prostate carcinogens.作为前列腺致癌物的内分泌干扰化学物质。
Nat Rev Urol. 2025 May 16. doi: 10.1038/s41585-025-01031-9.
3
Comparison of phenotypic and transcriptomic profiles between HFPO-DA and prototypical PPARα, PPARγ, and cytotoxic agents in wild-type and Ppara-null mouse livers.
野生型和Ppara基因敲除小鼠肝脏中HFPO-DA与典型PPARα、PPARγ及细胞毒性药物之间的表型和转录组图谱比较。
Toxicol Sci. 2025 Jul 1;206(1):183-201. doi: 10.1093/toxsci/kfaf049.
4
Hippo-vgll3 signaling may contribute to sex differences in Atlantic salmon maturation age via contrasting adipose dynamics.河马 - vgll3信号通路可能通过对比脂肪动态变化,导致大西洋鲑鱼成熟年龄出现性别差异。
Biol Sex Differ. 2025 Apr 2;16(1):23. doi: 10.1186/s13293-025-00705-8.
5
Immune-endocrine crossroads: the impact of nuclear receptors in Tuberculosis and Chagas disease.免疫 - 内分泌交叉点:核受体在结核病和恰加斯病中的影响。
Front Endocrinol (Lausanne). 2025 Feb 7;16:1538376. doi: 10.3389/fendo.2025.1538376. eCollection 2025.
6
Epigenetic dysregulation of metabolic programs mediates liposarcoma cell plasticity.代谢程序的表观遗传失调介导脂肪肉瘤细胞可塑性。
bioRxiv. 2025 Jan 24:2025.01.20.633920. doi: 10.1101/2025.01.20.633920.
7
The Role of microRNA-22 in Metabolism.微小RNA-22在新陈代谢中的作用。
Int J Mol Sci. 2025 Jan 17;26(2):782. doi: 10.3390/ijms26020782.
8
Peroxisome proliferator-activated receptor gamma mutation in familial partial lipodystrophy type three: A case report and review of literature.家族性3型部分脂肪营养不良中的过氧化物酶体增殖物激活受体γ突变:1例报告并文献复习
World J Diabetes. 2024 Dec 15;15(12):2360-2369. doi: 10.4239/wjd.v15.i12.2360.
9
Novel PPAR-γ agonists as potential neuroprotective agents against Alzheimer's disease: rational design, synthesis evaluation, PPAR-γ binding assay and transactivation and expression studies.新型PPAR-γ激动剂作为抗阿尔茨海默病的潜在神经保护剂:合理设计、合成评估、PPAR-γ结合测定以及反式激活和表达研究
RSC Adv. 2024 Oct 21;14(45):33247-33266. doi: 10.1039/d4ra06330a. eCollection 2024 Oct 17.
10
Longitudinal associations between microRNAs and weight in the diabetes prevention program.糖尿病预防计划中 microRNAs 与体重的纵向关联。
Front Endocrinol (Lausanne). 2024 Sep 18;15:1419812. doi: 10.3389/fendo.2024.1419812. eCollection 2024.